About Company
- Legal Name: Beijing Minhai Biotechnology Co., Ltd
- Registered country: China
- Address: No 35 Simiao Rd, Beijing • Beijing
- Number of employees: 1000 - 4999
- Established year: 2004
Description:
A pharmaceutical company specializing in vaccine development and manufacturing, with a portfolio including 13-valent and 23-valent pneumococcal conjugate/polysaccharide vaccines, hepatitis B vaccine, varicella vaccine, rabies vaccine, DTaP-Hib, DTaP, pentavalent vaccine, IPV vaccine, TT vaccine, MMR vaccine and quadrivalent influenza vaccine.
Business Activities
Biopharmaceutical Products
Manufacturer
Biological & Fermentation Ingredients
Biotech / Biopharmaceutical Company
ATC (Anatomical Therapeutic Chemical) Classification
Manufacturer
Key Products/Services
- Biopharmaceutical Products: R&D Research and Development, Human Vaccine, Paediatric combination vaccines, Vaccine contract production
- ATC (Anatomical Therapeutic Chemical) Classification: 13-valent pneumococcal conjugate vaccine, Varicella Vaccine, Live, Recombinant Hepatitis B vaccine (Saccharomyces cerevisiae
Our Products & Services
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Certifications
GMP
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment